ADMET chips integrate Absorption, Distribution, Metabolism, Excretion, and Toxicity testing on microfluidic platforms, revolutionizing preclinical drug development.
Gut-on-chip models simulate drug absorption through intestinal epithelium with realistic physiology.
Liver chips metabolize compounds using primary hepatocytes with proper CYP450 activity.
Multi-organ chips detect off-target toxicity before clinical trials begin.
Screen for metabolic interactions between multiple compounds in connected organ systems.
Generate pharmacokinetic data from integrated multi-tissue chip platforms.
FDA-qualified alternatives to animal testing for certain ADMET endpoints.
Patient Analog connects cutting-edge research with biotech intelligence infrastructure.
Explore Patient AnalogThis premium domain is available for acquisition. Submit your inquiry or make an offer below.